Avanos Medical Stock Performance
| AVNS Stock | USD 19.16 0.02 0.10% |
The firm shows a Beta (market volatility) of 1.62, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Avanos Medical will likely underperform. At this point, Avanos Medical has a negative expected return of -0.32%. Please make sure to confirm Avanos Medical's information ratio, as well as the relationship between the potential upside and rate of daily change , to decide if Avanos Medical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Avanos Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Actual Historical Performance (%)
One Day Return (0.10) | Five Day Return 4.99 | Year To Date Return (15.61) | Ten Year Return (50.66) | All Time Return (53.32) |
1 | Are Investors Undervaluing Avanos Medical Right Now - MSN | 09/20/2024 |
2 | Avanos Medical, Inc. Short Interest Down 7.0 percent in September | 10/17/2024 |
3 | Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2024 Financial Results | 10/23/2024 |
4 | Insider Trading | 10/28/2024 |
5 | Avanos Medical, Inc. Announces Third Quarter 2024 Results, retirement of CEO | 10/30/2024 |
6 | Avanos Medical Inc Q3 2024 Earnings Call Highlights Strong Financial Performance Amid ... | 10/31/2024 |
7 | Avanos Medical Third Quarter 2024 Earnings EPS US0.13 | 11/01/2024 |
8 | We Think Avanos Medicals Healthy Earnings Might Be Conservative | 11/06/2024 |
9 | Disposition of 2231 shares by Michael Greiner of Avanos Medical at 19.13 subject to Rule 16b-3 | 11/08/2024 |
10 | T. Rowe Price Investment Management, Inc. Expands Stake in Avanos Medical Inc | 11/14/2024 |
11 | Acquisition by Joseph Woody of 80933 shares of Avanos Medical subject to Rule 16b-3 | 11/22/2024 |
12 | Associated Banc Corp Sells 10,707 Shares of Avanos Medical, Inc. | 11/26/2024 |
| Begin Period Cash Flow | 127.7 M |
Avanos |
Avanos Medical Relative Risk vs. Return Landscape
If you would invest 2,408 in Avanos Medical on August 31, 2024 and sell it today you would lose (494.00) from holding Avanos Medical or give up 20.51% of portfolio value over 90 days. Avanos Medical is currently does not generate positive expected returns and assumes 2.874% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than Avanos, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Avanos Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Avanos Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Avanos Medical, and traders can use it to determine the average amount a Avanos Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1113
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AVNS |
Estimated Market Risk
| 2.87 actual daily | 25 75% of assets are more volatile |
Expected Return
| -0.32 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Avanos Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Avanos Medical by adding Avanos Medical to a well-diversified portfolio.
Avanos Medical Fundamentals Growth
Avanos Stock prices reflect investors' perceptions of the future prospects and financial health of Avanos Medical, and Avanos Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Avanos Stock performance.
| Return On Equity | 0.0177 | ||||
| Return On Asset | 0.0208 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 992.82 M | ||||
| Shares Outstanding | 45.96 M | ||||
| Price To Earning | 51.23 X | ||||
| Price To Book | 0.72 X | ||||
| Price To Sales | 1.29 X | ||||
| Revenue | 673.3 M | ||||
| Gross Profit | 450 M | ||||
| EBITDA | 50.6 M | ||||
| Net Income | (61.8 M) | ||||
| Cash And Equivalents | 106.5 M | ||||
| Cash Per Share | 2.26 X | ||||
| Total Debt | 209.1 M | ||||
| Debt To Equity | 0.24 % | ||||
| Current Ratio | 2.89 X | ||||
| Book Value Per Share | 26.73 X | ||||
| Cash Flow From Operations | 32.4 M | ||||
| Earnings Per Share | 0.47 X | ||||
| Market Capitalization | 879.62 M | ||||
| Total Asset | 1.69 B | ||||
| Retained Earnings | (314.9 M) | ||||
| Working Capital | 252.4 M | ||||
| Current Asset | 773.54 M | ||||
| Current Liabilities | 415.63 M | ||||
About Avanos Medical Performance
Assessing Avanos Medical's fundamental ratios provides investors with valuable insights into Avanos Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Avanos Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 202.89 | 112.01 | |
| Return On Tangible Assets | (0.09) | (0.09) | |
| Return On Assets | (0.04) | (0.03) | |
| Return On Equity | (0.05) | (0.05) |
Things to note about Avanos Medical performance evaluation
Checking the ongoing alerts about Avanos Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Avanos Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Avanos Medical generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 673.3 M. Net Loss for the year was (61.8 M) with profit before overhead, payroll, taxes, and interest of 450 M. | |
| Avanos Medical has a poor financial position based on the latest SEC disclosures | |
| Over 96.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Associated Banc Corp Sells 10,707 Shares of Avanos Medical, Inc. |
- Analyzing Avanos Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Avanos Medical's stock is overvalued or undervalued compared to its peers.
- Examining Avanos Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Avanos Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Avanos Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Avanos Medical's stock. These opinions can provide insight into Avanos Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Avanos Stock Analysis
When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.